Download PDF Press Release PeptiDream Announces Strategic Partnership with Drug-Delivery Expert PharmaIN Bothell, WA & Kanagawa, Japan – (June 5th, 2019) – PeptiDream Inc., a public Kanagawa-based biopharmaceutical company (“PeptiDream”)(TOKYO:4587) announced today a strategic partnership with Seattle-based PharmaIN Corporation (“PharmaIN”) for the purpose of investigating the use of
Read more →Press Release PharmaIN Corporation Announces Attendance at the 2019 J.P. Morgan Healthcare Conference. Bothell, WA, USA – 4 December 2018 PharmaIN Corporation announced its attendance at the J.P. Morgan Healthcare Conference, the largest and most informative healthcare investment symposium in the industry. This three-day event will be held on January 7-10, 2019 at
Read more →Press Release PharmaIN Corporation and Polypeptide Therapeutic Solutions (PTS) Announce Collaboration Agreement for Contract Manufacturing Bothell, WA & Valencia, Spain – 21st September 2018 PharmaIN Corporation and Polypeptide Therapeutic Solutions (PTS) announced today that they have entered into a collaboration agreement for contract manufacturing. Under the agreement,
Read more →Download PDF Press Release PharmaIN and Shionogi Announce Collaboration and $17M Securities Purchase Agreements Bothell, WA & Osaka, Japan – (January 4th, 2018) – PharmaIN Corporation and Shionogi & Co., LTD announced today that they entered into a Collaboration Agreement with an exclusive two-year Option to negotiate a License for
Read more →